Revised: 2 October 2019
Information for Industry

Guidance on the regulatory processes for suppliers in New Zealand of medicines and medical devices.
Industry News
Date | Type | Title |
---|---|---|
13/5/2022 | Consultation | Review of Fees payable under the Medicines Act 1981 |
11/5/2022 | COVID-19 | Adverse events following immunisation with COVID-19 vaccines: Safety Report #43 – 30 April 2022 |
24/4/2022 | Medicines | Minor Guidelines update: Part 4: Manufacture of Medicines: |
14/4/2022 | Committees | Reports from the 189th Medicines Adverse Reactions Committee Meeting |
14/4/2022 | Committees | Minutes of the 189th Medicines Adverse Reactions Committee Meeting |
13/4/2022 | COVID-19 | Adverse events following immunisation with COVID-19 vaccines: Safety Report #42 – 31 March 2022 |
10/4/2022 | Committees | Comments on agenda items for the 68th meeting of the Medicines Classification Committee to be held on 26 April 2022 |
5/4/2022 | Dear Healthcare Professional Letter | Supply of PAXLOVID (nirmatrelvir 150 mg/ritonavir 100 mg), film coated tablets |
30/3/2022 | Committees | Reclassification of Pholcodine |
If you have a query that is not answered by the information in this section please contact us at askmedsafe@health.govt.nz